Hill-Rom (NYSE:HRC) updated its FY19 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $5.08-5.16 for the period, compared to the Thomson Reuters consensus estimate of $5.08. The company issued revenue guidance of $2.88-2.90 billion (+1-2%), compared to the consensus revenue estimate of $2.93 billion.Hill-Rom also updated its FY 2019 guidance to $5.08-5.16 EPS.
Several equities research analysts recently commented on the company. KeyCorp raised their target price on Hill-Rom from $97.00 to $115.00 and gave the stock an overweight rating in a research note on Tuesday, July 17th. Raymond James raised their target price on Hill-Rom from $97.00 to $100.00 and gave the stock an outperform rating in a research note on Monday, July 30th. Zacks Investment Research cut Hill-Rom from a buy rating to a hold rating in a research note on Wednesday, August 1st. Northcoast Research reaffirmed a buy rating and set a $104.00 target price on shares of Hill-Rom in a research note on Tuesday, July 31st. Finally, ValuEngine raised Hill-Rom from a hold rating to a buy rating in a research note on Tuesday, July 31st. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of Hold and an average price target of $99.44.
Shares of Hill-Rom stock opened at $91.06 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.58 and a debt-to-equity ratio of 1.24. Hill-Rom has a 52 week low of $75.21 and a 52 week high of $98.96. The company has a market capitalization of $6.05 billion, a price-to-earnings ratio of 19.17, a PEG ratio of 1.29 and a beta of 0.90.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, November 2nd. The medical technology company reported $1.63 EPS for the quarter, beating the Zacks’ consensus estimate of $1.51 by $0.12. Hill-Rom had a return on equity of 20.54% and a net margin of 8.19%. The firm had revenue of $759.20 million during the quarter, compared to analysts’ expectations of $750.90 million. During the same quarter last year, the firm posted $1.32 earnings per share. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. As a group, research analysts predict that Hill-Rom will post 5.09 EPS for the current year.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
See Also: What is the NASDAQ Stock Market?
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.